Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 244

The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.

Antiangiogenic Agents Are Effective Inhibitors of Endometriosis

Hull, M. Louise, Charnock-Jones, D. Stephen, Chan, Clement L. K., Bruner-Tran, Kaylon L., Osteen, Kevin G., Tom, Brian D. M., Fan, Tai-Ping D., Smith, Stephen K. · 2003 · The Journal of Clinical Endocrinology & Metabolism

Abstract

Endometriosis is a disease in which the lining of the uterus (endometrium), shed at the time of menstruation, becomes established at sites such as the peritoneum and ovaries. These explants develop a rich blood supply that enables them to survive and grow. We hypothesized that inhibitors of angiogenesis would prevent this growth by disrupting sensitive vessels supplying endometriotic lesions. Vessels sensitive to angiogenic antagonism have few associations with pericyte cells. The vessels supplying human endometriotic lesions were immunohistochemically characterized and found to be predominantly pericyte free. A model in which human endometrium is implanted into nude mice was used to test the effects of two antagonists of the angiogenic growth factor, vascular endothelial cell growth factor A. Soluble truncated receptor (flt-1; P = 0.002) and an affinity-purified antibody to human vascular endothelial cell growth factor A (P = 0.03) significantly inhibited the growth of nude mouse explants. Pericyte-free vessels were shown to supply endometrial lesions in nude mice and were disrupted in lesions taken from soluble flt-1-treated mice. In summary, antiangiogenic agents inhibited the growth of explants in an in vivo model of endometriosis by disrupting the vascular supply, and this effect is likely to apply to the human disease. These findings suggest that antiangiogenic agents may provide a novel therapeutic approach for the treatment of endometriosis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/jc.2002-021912

Cites

6 of 6 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 6 references

Cited by

See all 244

Metadata

Authors
Hull, M. L., Charnock-Jones, D. S., Chan, C. L. K., Bruner-Tran, K. L., Osteen, K. G., Tom, B. D. M., Fan, T.-P. D., & Smith, S. K.
Venue
The Journal of Clinical Endocrinology & Metabolism
Published
2003-06
Volume
88
Issue
6
Pages
2889-2899
ISSN
  • 0021-972X (ISSN-L)
  • 1945-7197
OpenAlex
W2056951482
Cited by
244
References
6
FWCI
14.84
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Antiangiogenic Agents Are Effective Inhibitors of Endometriosis. https://app.cochat.ai/papers/10.1210/jc.2002-021912
The paper
Hull, M. L., Charnock-Jones, D. S., Chan, C. L. K., Bruner-Tran, K. L., Osteen, K. G., Tom, B. D. M., Fan, T.-P. D., & Smith, S. K. (2003). Antiangiogenic Agents Are Effective Inhibitors of Endometriosis. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/jc.2002-021912

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.